Atractylenolide promotes trophoblast cell proliferation and migration in recurrent spontaneous abortion via ERK pathway

被引:0
作者
Lv, Beili [1 ]
Wang, Haiyan [1 ]
Li, Xinrong [1 ]
Tang, Minjie [1 ]
机构
[1] Obstet & Gynecol Hosp, Dept Integrated Tradit Chinese Med & Western Med, Shanghai 200011, Peoples R China
关键词
Atractylenolide; Trophoblast cell; Proliferation; Migration; Invasion; INVASION;
D O I
10.4314/tjpr.v22i8.3
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Purpose: To investigate the effect of atractylenolide on recurrent spontaneous abortion (RSA).Methods: The HTR-8/SVneo was established as an in vitro cell model of RSA. Cell viability and proliferation were determined using CCK8 and BrdU staining, while cell migration and invasion were determined by cell scratch and transwell assays.Results: Atractylenolide significantly increased cell viability, and enhanced the number of BrdU-positive cells of HTR-8/SVneo (p < 0.01). Atractylenolide also significantly promoted cell migration and invasion (p < 0.01), and increased protein expression of MMP-9, MMP-2, and N-cadherin, but reduced E-cadherin. Atractylenolide also increased the phosphorylation of ERK (p < 0.01).Conclusion: Atractylenolide enhances cell proliferation and migration of HTR-8/SVneo through activation of ERK signaling. Further studies using animal models are recommended to determine the protective role of atractylenolide against RSA, in vivo.
引用
收藏
页码:1547 / 1551
页数:5
相关论文
共 50 条
  • [31] Elevated PGT promotes proliferation and inhibits cell apoptosis in preeclampsia by Erk signaling pathway
    Pang, Huiyuan
    Lei, Di
    Huang, Jinfa
    Guo, Yuping
    Fan, Cuifang
    MOLECULAR AND CELLULAR PROBES, 2023, 67
  • [32] Block of proliferation 1 promotes cell migration and invasion in human colorectal cancer cells via the JNK pathway
    Chen, Xiaoxi
    Zhao, Yu
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2020, 34 (07)
  • [33] Ellagic acid inhibits cell proliferation, migration, and invasion in melanoma via EGFR pathway
    Wang, Fan
    Chen, Jiangyan
    Xiang, Debing
    Lian, Xiaojuan
    Wu, Chunrong
    Quan, Jin
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2020, 12 (05): : 2295 - 2304
  • [34] Osteopontin regulates trophoblast proliferation and invasion and associates with spontaneous abortion during early pregnancy
    Zhou, Hui
    Xu, Wang-Ming
    Qi, Qian-Rong
    Xie, Qing-Zhen
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 9 (05): : 5230 - 5239
  • [35] Hypoxia-induced DEC1 mediates trophoblast cell proliferation and migration via HIF1α signaling pathway
    Hu, Rui
    Wang, Qi
    Jia, Yanfei
    Zhang, Yingchun
    Wu, Bin
    Tian, Shan
    Wang, Yujie
    Wang, Yunshan
    Ma, Wanshan
    TISSUE & CELL, 2021, 73
  • [36] CMTM4 inhibits cell proliferation and migration via AKT, ERK1/2, and STAT3 pathway in colorectal cancer
    Xue, Hui
    Li, Ting
    Wang, Pingzhang
    Mo, Xiaoning
    Zhang, Hejun
    Ding, Shigang
    Ma, Dalong
    Lv, Wenping
    Zhang, Jing
    Han, Wenling
    ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2019, 51 (09) : 915 - 924
  • [37] HLA-C promotes proliferation and cell cycle progression in trophoblast cells
    Lv, Hong
    Zhou, Qian
    Li, Lie
    Wang, Shan
    JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2021, 34 (04) : 512 - 518
  • [38] USP22 promotes aspirin-induced trophoblast cell proliferation as well as migration via Wnt/β-catenin pathway in preeclampsia
    Zhang, Changcun
    Han, Qiping
    Luoji, E.
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2023, 22 (05) : 987 - 992
  • [39] CEP55 promotes the proliferation, migration and invasion of esophageal squamous cell carcinoma via the PI3K/Akt pathway
    Jia, Yang
    Xiao, Zhaohua
    Xin Gongsun
    Xin, Zhongwei
    Shang, Bin
    Chen, Gang
    Wang, Zhou
    Jiang, Wenpeng
    ONCOTARGETS AND THERAPY, 2018, 11 : 4221 - 4232
  • [40] PRR11 Promotes Proliferation and Migration of Colorectal Cancer through Activating the EGFR/ERK/AKT Pathway via Increasing CTHRC1
    Ma, Hualing
    Yang, Weigui
    Wang, Xiufang
    Dai, Gang
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2022, 52 (01) : 86 - 94